News Archives - IIS Biodonostia

Biodonostia participa en la reunión anual de EATRIS

Una representación del IIS Biodonostia ha acudido recientemente a la Annual Meeting de la Plataforma Europea para la Medicina Traslacional, EATRIS, organizado por el Nodo Nacional EATRIS-Portugal, que ha tenido lugar en la sede de INFARMED en Lisboa. EATRIS realiza encuentros anuales en sus diferentes nodos donde se abordan temas concretos ... + info

Merry Christmas!

With good wishes for Christmas.

Biodonostia leads the research to reduce the time taken to make treatment decisions for lung cancer patients

The Molecular Oncology Group of Biodonostia Health Research Institute (HRI) has been leading a project INDICATE (IN vitro DIagnostic CAncer TEst) that aims to develop a simple, economical and rapid test to detect clinically relevant cancer-associated mutations in the blood of patients in a point-of-care (POC) format similar to the pregnancy ... + info

Researchers at Biodonostia discover that four inner cell contacts drive the mouse embryo from totipotency to pluripotency

A non-cell autonomous mechanism, based on a minimal number of four inner-cell contacts in the Inner Cell Mass (ICM) of the mouse embryo at E(mbryonic day)3.25 activates the pluripotency master regulator Oct4 and establishes in vivo a very early naïve pluripotent state. Research, led by Dr. Marcos J. Araúzo Bravo from the Computational ... + info

Biodonostia hosts the EATRIS-Spain conference on Translational Medicine and Research

The conference included presentation of the European infrastructure for translational medicine, EATRIS, which enables fast and personalised access to state-of-the-art technologies, bringing them closer to patients On May 3, the Biodonostia HRI headquarters hosted a meeting of the members of EATRIS Spain, with the participation of 15 of its ... + info

Biodonostia presents its advances on the Strategy of Research on Aging

On April 4, at Biodonostia, a presentation was made of the Strategy of Research on Aging developed by the Institute, focussed on presenting the lines of research which have gradually emerged, as well as the results of several studies carried out in the last five years. The event, which was opened by the Director of […]

Researchers at Biodonostia develop a kit to detect and identify variants of one of the main agents responsible for respiratory infections

The agent is associated to benign infections such as acute otitis media and sinusitis, as well as to severe infections such as bacteraemia, meningitis and pneumonia. Researchers from the Respiratory Infection and Antimicrobial Resistance Group of Osakidetza’s Biodonostia Health Research Institute (HRI)-Donostialdea IHO have developed this ... + info

Researchers at Biodonostia and Ibima identify a method to obtain stem cells from human muscle

Using these cells represents advantages for cell therapy in patients suffering from urinary or anal incontinence with sphincter muscle damage, or for treating small-sized muscle groups, such as in the case of oculopharyngeal muscular dystrophy or facioscapulohumeral dystrophy. . Researchers at the Biodonostia Health Research Institute ... + info

Over 60% of Hearing Deficits in Newborns Are of Genetic Origin

Recently, was presented an international study for the early diagnosis of hipoacusias by means of genomic tools (GHELP project), led by the University of Navarra Clinic, in which 8 other centres from Spain, Portugal and France participate, including the IIS Biodonostia. Five out of every thousand children are born with some type of hearing ... + info

Biodonostia researcher Jesús Bañales co-heads a European Horizon 2020 project addressing 3 types of liver cancer

The research project is part of the European Research and Innovation Programme Horizon 2020, one of the most competitive and prestigious at international level, and is funded with €3.5 million. An international consortium co-headed by Dr Jesús Bañales, Head of the Hepatic Diseases Group at Osakidetza’s Biodonostia Health Research ... + info

BioNet Access